Investments
17Portfolio Exits
9Latest Knott Partners News
May 4, 2022
16h agoPrivate Equitylaw360Views: 42 An investor in a Tampa, Florida-based company that develops chat-bot technology sued the company and its CEO in Delaware's Court of Chancery, alleging the company is violating its charter and Delaware law by not putting more than one person on its board. Not a member yet? Breaking News 24/7/365 ALL ALPHAMAVEN CONTENT IS FOR INFORMATIONAL PURPOSES ONLY.CONTENT POSTED BY MEMBERS DOES NOT NECESSARILY REFLECT THE OPINION OR BELIEFS OF ALPHAMAVEN AND HAS NOT ALWAYS BEEN INDEPENDENTLY VERIFIED BY ALPHAMAVEN.PAST PERFORMANCE IS NOT INDICATIVE OF FUTURE RESULTS.THIS IS NOT A SOLICITATION FOR INVESTMENT.THE MATERIAL PROVIDED HEREIN IS FOR INFORMATIONAL PURPOSES ONLY.IT DOES NOT CONSTITUTE AN OFFER TO SELL OR A SOLICITATION OF AN OFFER TO BUY ANY INTERESTS OF ANY FUND OR ANY OTHER SECURITIES.ANY SUCH OFFERINGS CAN BE MADE ONLY IN ACCORDANCE WITH THE TERMS AND CONDITIONS SET FORTH IN THE INVESTMENT'S PRIVATE PLACEMENT MEMORANDUM.PRIOR TO INVESTING, INVESTORS ARE STRONGLY URGED TO REVIEW CAREFULLY THE PRIVATE PLACEMENT MEMORANDUM (INCLUDING THE RISK FACTORS DESCRIBED THEREIN), THE LIMITED PARTNERSHIP AGREEMENT AND THE SUBSCRIPTION DOCUMENTS, TO ASK SUCH QUESTIONS OF THE INVESTMENT MANAGER AS THEY DEEM APPROPRIATE, AND TO DISCUSS ANY PROSPECTIVE INVESTMENT IN THE FUND WITH THEIR LEGAL AND TAX ADVISERS IN ORDER TO MAKE AN INDEPENDENT DETERMINATION OF THE SUITABILITY AND CONSEQUENCES OF AN INVESTMENT. ALPHAMAVEN
Knott Partners Investments
17 Investments
Knott Partners has made 17 investments. Their latest investment was in Columbia Laboratories as part of their Unattributed VC - IV on December 12, 2006.
Knott Partners Investments Activity
Date | Round | Company | Amount | New? | Co-Investors | Sources |
|---|---|---|---|---|---|---|
12/11/2006 | Unattributed VC - IV | Columbia Laboratories | $40M | No | ||
6/13/2006 | PIPE - II | IPIX | $5M | No | ||
5/5/2006 | PIPE | Ziopharm Oncology | $37M | Yes | Abu Dhabi Investment Authority, Andrew Carter Capital, Broadlawn Capital Management, Bushido Capital Partners, Clarion Capital Partners, Cycad Group, Dorset Management Corporation, Downsview Capital, Emerging Technology Center, FCP OP MEDICAL BioHelth-Trends, H & A Lux VCH Expert Biotech, Hackney Group, Hauck & Aufhauser, Henderson Global Investors, Highbridge Capital Management, Hollis Capital Management, Iroquois Capital Group, LBi International, Lewis Asset Management, Medical Strategy, Mehta Partners, Millennium Management, Mosaix Ventures, Panacea Asset Management, ProQuest Investments, Quantitative Bioequities Management, Riverside Contracting, Sterling Securities International, and Visium Asset Management | |
3/14/2006 | Unattributed VC - III | |||||
10/5/2005 | PIPE |
Date | 12/11/2006 | 6/13/2006 | 5/5/2006 | 3/14/2006 | 10/5/2005 |
|---|---|---|---|---|---|
Round | Unattributed VC - IV | PIPE - II | PIPE | Unattributed VC - III | PIPE |
Company | Columbia Laboratories | IPIX | Ziopharm Oncology | ||
Amount | $40M | $5M | $37M | ||
New? | No | No | Yes | ||
Co-Investors | Abu Dhabi Investment Authority, Andrew Carter Capital, Broadlawn Capital Management, Bushido Capital Partners, Clarion Capital Partners, Cycad Group, Dorset Management Corporation, Downsview Capital, Emerging Technology Center, FCP OP MEDICAL BioHelth-Trends, H & A Lux VCH Expert Biotech, Hackney Group, Hauck & Aufhauser, Henderson Global Investors, Highbridge Capital Management, Hollis Capital Management, Iroquois Capital Group, LBi International, Lewis Asset Management, Medical Strategy, Mehta Partners, Millennium Management, Mosaix Ventures, Panacea Asset Management, ProQuest Investments, Quantitative Bioequities Management, Riverside Contracting, Sterling Securities International, and Visium Asset Management | ||||
Sources |
Knott Partners Portfolio Exits
9 Portfolio Exits
Knott Partners has 9 portfolio exits. Their latest portfolio exit was Spectrum Pharmaceuticals on June 24, 2017.
Date | Exit | Companies | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Acquirer | Sources |
|---|---|---|---|---|---|
6/24/2017 | Acq - P2P | 2 | |||
Date | 6/24/2017 | ||||
|---|---|---|---|---|---|
Exit | Acq - P2P | ||||
Companies | |||||
Valuation | |||||
Acquirer | |||||
Sources | 2 |
Knott Partners Acquisitions
1 Acquisition
Knott Partners acquired 1 company. Their latest acquisition was Ventyx on January 18, 1999.
Date | Investment Stage | Companies | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Total Funding | Note | Sources |
|---|---|---|---|---|---|---|
1/18/1999 | Acquired |
Date | 1/18/1999 |
|---|---|
Investment Stage | |
Companies | |
Valuation | |
Total Funding | |
Note | Acquired |
Sources |
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.